Convincing Data Needed to Perpetuate Premium for New Drug Development: Mr Yoshida of MED

March 13, 2012
Yasunori Yoshida, Pharmaceutical Management Director Yasunori Yoshida, pharmaceutical management director of the Health Insurance Bureau’s Medical Economics Division (MED), told Jiho, Inc. on March 12 that the chances of perpetuating the premium for new drug development and elimination of off-label...read more